Status:
RECRUITING
Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
Lead Sponsor:
The Netherlands Cancer Institute
Conditions:
Early-onset Colorectal Cancer
Eligibility:
All Genders
18-49 years
Brief Summary
The study aims to collect high quality clinical data on lifestyle and patient biomaterials prior to start or during / after treatment of early-onset colorectal cancer (EOCRC) and to inform on treatmen...
Detailed Description
The current study will be complementary to COMPRAYA, a prospective cohort study focused on risk factors of impaired medical and psychosocial outcomes of adolescents and young adults with cancer (AYA) ...
Eligibility Criteria
Inclusion
- Patients with locoregional or metastatic colorectal cancer (CRC)
- Histologically proven CRC
- Age 18 - 49 years at time of first CRC diagnosis
- Able to understand the informed consent form
- Provide written informed consent.
Exclusion
- Mentally incompetent patients based on the opinion of treating physician
- Inability to understand the Dutch language
Key Trial Info
Start Date :
January 27 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2038
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06568679
Start Date
January 27 2025
End Date
December 1 2038
Last Update
August 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Netherlands Cancer Institute
Amsterdam, North Holland, Netherlands, 1066CX